Oncosem Oncological Systems Industry and Trade Inc. is offered to the public on Borsa Istanbul. Oncosem Oncology Systems completed the bookkeeping process after the Borsa Istanbul and CMB audits. The company is expected to start trading on Borsa Istanbul with the “Gong Ceremony” to be held on January 4, 2023. Oncosem Chairman of the Board Erol Çelik said, “We have started the process of capital markets in order to create a global structure that can dominate the world market.” A global structure will be created Erol Çelik, Chairman of Oncosem Oncological Systems, said that the public offering process benefited the company in testing institutionalism. Çelik said, “We are currently the market leader in Turkey. In fact, one out of every two patients is treated with high-tech systems and equipment produced in our facility. We have started the process regarding the capital markets in order to create a global structure that can dominate the world market.” No geographic distinction in target markets Stating that they are in a position to enter all target markets regardless of geography, Çelik stated that they export to more than 30 countries in Africa, Europe, Central Asia and America and that the share of exports in their total income is 25 percent. “Replacing our domestic revenues with our foreign revenues. In other words, we have a target of obtaining 75 percent of our revenues from abroad,” he said. Stating that they will allocate most of the money from the public offering to the machinery infrastructure to switch to automated production, Çelik stated that they will switch to a 90 percent automated production process in 2023 and that this will increase their capacity by 6-7 times. Çelik said that they will use the remaining part for the development of target markets with new factory investment. Speaking about his promises to his investors, Çelik said, “We have made our 1-1.5 and 5-year plans. There will be no paid or bonus capital increase with a share sale for 18 months. For 5 years, a minimum of 40 percent of the company’s profit will be distributed as dividends.” . CMB approves public offering of two companies The Capital Markets Board (SPK) approved the public offering of Tapdi Oxygen Private Health and Education Services Industry Trade at 10.21 liras per share, and Mackolik Internet Hizmetleri Ticaret at 38 liras per share.